Skip to main content
Gayatri BioOrganics Ltd logo

Gayatri BioOrganics Ltd — Investor Relations & Filings

Ticker · 524564 ISIN · INE052E01015 BSE.NS Manufacturing
Open in API
Filings indexed 6 across all filing types
Latest filing 2026-05-19 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS 524564

About Gayatri BioOrganics Ltd

https://www.gayatribioorganics.com

Gayatri BioOrganics Ltd specializes in the production of starch and its various derivatives. The company's core product portfolio includes maize starch, liquid glucose, sorbitol, and maltodextrin. These products serve a diverse range of applications across the food and beverage, pharmaceutical, textile, paper, and cosmetic sectors. In addition to its primary offerings, the company produces several by-products such as maize gluten, maize germ, and fiber, which are utilized in the animal feed industry. Gayatri BioOrganics focuses on large-scale manufacturing processes and bio-organic chemical production to meet the technical requirements of industrial clients. The company maintains a focus on quality standards and process efficiency within the starch-based chemical manufacturing domain.

Recent filings

Filing Released Lang Actions
Submission of Revised Audited Financial Results for the Quarter and Year Ended 31.03.2026 due to typographical error for Board Meeting held on 19.05.2026
Interim / Quarterly Report Classification · 90% confidence The document comprises the company’s revised audited financial results for the quarter and year ended March 31, 2026, including detailed statements of assets and liabilities, profit and loss, cash flows, accompanying notes, and the Independent Auditor’s Report. It has been filed pursuant to SEBI Regulation 33 for quarterly and year-end results and contains actual financial statements and disclosures rather than merely announcing a report or providing a link. This is not a full Annual Report (10-K) but a comprehensive periodic financial results filing. Therefore, it fits the definition of an Interim/Quarterly Report. FY 2026
2026-05-19 English
Submission of Revised Audited Financial Results for the Quarter and year Ended 31.03.2026 for Board Meeting held on 19.05.2026
Interim / Quarterly Report Classification · 90% confidence The document is a submission to BSE of the company’s revised audited financial results for the quarter and year ended March 31, 2026. It contains the full financial statements (statement of assets & liabilities, profit & loss, cash flows, notes) along with the Independent Auditor’s Report. This is more than a brief earnings release and clearly presents substantive financial data for an interim period (quarter/end of year). It is not the full Annual Report but an audited quarterly/interim financial report as required by SEBI Regulation 33. Therefore, it should be classified as an Interim / Quarterly Report (IR). FY 2026
2026-05-19 English
Re- Appointment of M/s. Vas & Co., Chartered Accountants as Internal Auditors of the Company for Financial Year 2026-27
Interim / Quarterly Report Classification · 85% confidence The document is the formal BSE filing of audited financial results (quarterly and year-end statements) approved at the Board meeting on May 19, 2026. It includes the full statement of assets & liabilities, profit & loss, cash flows, notes, and the auditor’s report. This is a periodic financial report rather than a full annual report (10-K) or just a brief earnings highlight, and it clearly contains substantive financial statements for the quarter/year. Therefore it falls under Interim/Quarterly Report (IR). FY 2026
2026-05-19 English
Outcome of Board Meeting held on 19.05.2026
Interim / Quarterly Report Classification · 85% confidence The document is an official board meeting outcome announcing and enclosing the company’s audited financial results for the quarter and year ended March 31, 2026 along with the auditor’s report, balance sheet, statement of profit and loss, cash flows and notes. It contains full financial statements and is not merely a short “report published” notice (RPA), nor a full annual report (10-K) with narrative, nor a simple earnings summary (ER). It is a standalone periodic financial report under SEBI Regulation 33—thus an Interim/Quarterly Report (IR). FY 2026
2026-05-19 English
Audited Financial Results along with Audit Report for quarter and year ended 31.03.2026
Interim / Quarterly Report Classification · 95% confidence The document is the outcome of a board meeting submitted to the stock exchange under SEBI LODR Reg. 33, containing the full audited financial results for the quarter and year ended 31 March 2026—including the statement of assets & liabilities, statement of profit & loss, cash flow statement, notes and auditor’s report. This goes beyond a mere earnings release or announcement: it is a complete set of interim/quarterly (here Q4 plus annual) financial statements filed with the exchange. Therefore, it should be classified as an Interim / Quarterly Report. FY 2026
2026-05-19 English
Gayatri Bioorganics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve the Audited financial results ....
Regulatory Filings Classification · 35% confidence The document is a formal notice to the stock exchange informing of an upcoming Board of Directors meeting date and agenda. It does not present any financial data or actual report content, nor does it announce a change in board composition or senior management. This is a routine regulatory announcement to the exchange, falling into the catch-all category for such filings.
2026-05-12 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.